ScholarIQanswers from OpenAlex & ORCID
Andreas Wollenberg
ResearcherPublications, citations & collaboration network
Andreas Wollenberg is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Andreas Wollenberg have?
ScholarIQindexed works
Andreas Wollenberg has 570 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Andreas Wollenberg have?
ScholarIQcitation count
Andreas Wollenberg has 29,469 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Andreas Wollenberg?
ScholarIQh-index
Andreas Wollenberg has an h-index of 81 in OpenAlex.
What is the i10-index of Andreas Wollenberg?
ScholarIQi10-index
Andreas Wollenberg has an i10-index of 278 in OpenAlex.
What is the ORCID of Andreas Wollenberg?
ScholarIQorcid
The ORCID for Andreas Wollenberg is on the source record.
What is the OpenAlex record for Andreas Wollenberg?
ScholarIQopenalex
The OpenAlex for Andreas Wollenberg is on the source record.
What are the most-cited papers on Andreas Wollenberg?
ScholarIQmost cited works
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky, Lisa A. Beck, Andrew Blauvelt, Michael J. Cork, Jonathan I. Silverberg, Mette Deleuran, Yoko Kataoka, J.‐P. Lacour, Külli Kingo, Margitta Worm, Yves Poulin, Andreas Wollenberg, Yuhwen Soo, Neil M.H. Graham, Gianluca Pirozzi, Bolanle Akinlade, Heribert Staudinger, Vera Mastey, Laurent Eckert, Abhijit Gadkari, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu
Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
Andreas Wollenberg, S. Barbarot, Thomas Bieber, Stéphanie Christen‐Zaech, Mette Deleuran, A. Fink‐Wagner, Uwe Gieler, Giampiero Girolomoni, S. Lau, Antonella Muraro, Magdalena Czarnecka‐Operacz, T. Schäfer, Peter Schmid‐Grendelmeier, Dagmar Simon, Zsuzsanna Szalai, Jacek C. Szepietowski, Alain Taı̈eb, Antonio Torrelo, Thomas Werfel, Johannes Ring
Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II
Andreas Wollenberg, S. Barbarot, Thomas Bieber, Stéphanie Christen‐Zaech, Mette Deleuran, A. Fink‐Wagner, Uwe Gieler, Giampiero Girolomoni, S. Lau, Antonella Muraro, Magdalena Czarnecka‐Operacz, T. Schäfer, Peter Schmid‐Grendelmeier, Dagmar Simon, Zsuzsanna Szalai, Jacek C. Szepietowski, Alain Taı̈eb, Antonio Torrelo, Thomas Werfel, Johannes Ring
Guidelines for treatment of atopic eczema (atopic dermatitis) Part I
Johannes Ring, A. Alomar, Thomas Bieber, Mette Deleuran, A. Fink‐Wagner, C. Gelmetti, Uwe Gieler, Jasna Lipozenčić, Thomas A. Luger, A. P. Oranje, T. Schäfer, Thomas Schwennesen, Stefania Seidenari, Dagmar Simon, Sonja Ständer, Georg Stingl, S. Szalai, Jacek C. Szepietowski, Alain Taı̈eb, Thomas Werfel, Andreas Wollenberg, Ulf Darsow
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*
Andreas Wollenberg, Andrew Blauvelt, Emma Guttman‐Yassky, Margitta Worm, Charles Lynde, J.‐P. Lacour, Lynda Spelman, Norito Katoh, Hidehisa Saeki, Yves Poulin, Aleksandra Lesiak, Leon Kircik, S.H. Cho, Pedro Herranz, Michael J. Cork, Ketty Peris, Louise Abildgaard Steffensen, B K Bang, Alexandra Kuznetsova, T.N. Jensen, Marie Louise Østerdal, Eric L. Simpson, the ECZTRA 1 and ECZTRA 2 study investigators